In a randomised, open-label, two-way, cross-over study among T2DM patients treated with insulin glargine versus NPH insulin, it was reported that both insulin glargine and NPH insulin provided similar improvements in terms of glycaemic control (27). Here, INS is linked to type 2 diabetes mellitus.